Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:FIXX

Homology Medicines (FIXX) Stock Price, News & Analysis

Homology Medicines logo

About Homology Medicines Stock (NASDAQ:FIXX)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.33
$16.82
52-Week Range
N/A
Volume
22,300 shs
Average Volume
390,307 shs
Market Capitalization
$978.01 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive FIXX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Homology Medicines and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

FIXX Stock News Headlines

Tax Drain Deadline: Protect Your Wealth Before September 15th
On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed professionals, retirees, and high-net-worth savers. But the wealthy aren’t just writing checks. They’re moving fast to protect capital and purchasing power using legal, IRS-compliant strategies. American Alternative Assets just released the Mar-A-Lago Accord, a free guide revealing how to reduce Q3 tax exposure and reposition wealth before it’s drained.tc pixel
FIXX Homology Medicines, Inc.
Homology Medicines Inc (FIXX)
See More Headlines

FIXX Stock Analysis - Frequently Asked Questions

Homology Medicines, Inc. (NASDAQ:FIXX) released its earnings results on Monday, November, 15th. The company reported ($0.27) EPS for the quarter, topping analysts' consensus estimates of ($0.30) by $0.03. The firm earned $1.68 million during the quarter, compared to analyst estimates of $0.63 million. Homology Medicines had a negative net margin of 4,779.31% and a negative trailing twelve-month return on equity of 102.52%.

Homology Medicines shares split on the morning of Wednesday, March 20th 2024.The 2-1 split was announced on Wednesday, March 20th 2024. The newly issued shares were distributed to shareholders after the market closes on Wednesday, March 20th 2024. An investor that had 100 shares of stock prior to the split would have 200 shares after the split.

Homology Medicines (FIXX) raised $100 million in an initial public offering on Wednesday, March 28th 2018. The company issued 6,700,000 shares at a price of $14.00-$16.00 per share. BofA Merrill Lynch, Cowen and Evercore ISI served as the underwriters for the IPO and BTIG was co-manager.

Based on aggregate information from My MarketBeat watchlists, some other companies that Homology Medicines investors own include Editas Medicine (EDIT), NVIDIA (NVDA), Enovix (ENVX), Luminar Technologies (LAZR), Advanced Micro Devices (AMD), Ginkgo Bioworks (DNA) and Tesla (TSLA).

Company Calendar

Last Earnings
11/15/2021
Today
8/28/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:FIXX
CIK
1661998
Fax
N/A
Employees
7
Year Founded
2015

Profitability

EPS (Trailing Twelve Months)
($1.96)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$112.96 million
Net Margins
-4,779.31%
Pretax Margin
-7,532.87%
Return on Equity
-102.52%
Return on Assets
-74.91%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
7.25
Quick Ratio
7.25

Sales & Book Value

Annual Sales
$1.16 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.26 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
58,130,000
Free Float
48,774,000
Market Cap
$978.01 million
Optionable
Optionable
Beta
-0.10

Social Links

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (NASDAQ:FIXX) was last updated on 8/28/2025 by MarketBeat.com Staff
From Our Partners